Liu K J, Shi X, Jiang J, Goda F, Dalal N, Swartz H M
Department of Radiology, Dartmouth Medical School, Hanover, NH 03755, USA.
Ann Clin Lab Sci. 1996 Mar-Apr;26(2):176-84.
Detection of Cr(V) in the reduction of Cr(VI) by whole live mice and its characterization were carried out by low frequency electron paramagnetic resonance (EPR). Intravenous injection of Cr(VI) to mice generated Cr(V). The Cr(V) was found predominantly in the liver with a small amount in the blood. Liver homogenates from Cr(VI) treated mice generated essentially the same Cr(V) spectrum as that obtained from the whole live mice. This Cr(V) species was identified to be a Cr(V)-nicotinamide adenine dinucleotide (NAD) (P)H complex with an oxygen bond to Cr(V). Pretreatment of the mice with ascorbic acid and glutathione reduced the Cr(V) formation, while pretreatment with reduced nicotinamide adenine dinucleotide (NADH) enhanced it. Metal chelators, ethylenediaminetetraacetic acid (EDTA), 1,10-phenanthroline, and diethylenetriaminepentaacetic acid (DTPA) inhibited the intensity of the Cr(V) signal. The results suggest that Cr(V) generated in the whole body of a live animal is a Cr(V)-NAD(P)H complex and NAD(P)H/flavoenzymes and not glutathione or ascorbate as the major one-electron Cr(VI) reductant responsible for observed formation of Cr(V)-NAD(P)H complex in vivo.
通过低频电子顺磁共振(EPR)对全活小鼠体内六价铬(Cr(VI))还原过程中五价铬(Cr(V))的检测及其特性进行了研究。向小鼠静脉注射六价铬可产生五价铬。五价铬主要存在于肝脏中,血液中含量较少。经六价铬处理的小鼠肝脏匀浆产生的五价铬光谱与全活小鼠产生的基本相同。这种五价铬物种被鉴定为与五价铬形成氧键的五价铬 - 烟酰胺腺嘌呤二核苷酸(NAD)(P)H复合物。用抗坏血酸和谷胱甘肽对小鼠进行预处理可减少五价铬的形成,而用还原型烟酰胺腺嘌呤二核苷酸(NADH)预处理则会增强其形成。金属螯合剂乙二胺四乙酸(EDTA)、1,10 - 菲咯啉和二乙烯三胺五乙酸(DTPA)抑制了五价铬信号的强度。结果表明,活动物体内产生的五价铬是一种五价铬 - NAD(P)H复合物,并且NAD(P)H/黄素酶而非谷胱甘肽或抗坏血酸是体内观察到的五价铬 - NAD(P)H复合物形成的主要单电子六价铬还原剂。